Cite
HARVARD Citation
Chiang, N. et al. (2020). A multicenter, phase I/II trial of biweekly S-1, leucovorin, oxaliplatin and gemcitabine in metastatic pancreatic adenocarcinoma–TCOG T1211 study. European journal of cancer. pp. 123-130. [Online].